Bill > SB1403

This bill establishes new regulations for prescription drug pricing in Arizona, focusing on limiting the cost of certain drugs to their "maximum fair price" as defined by federal guidelines. Specifically, the bill defines key terms such as "maximum fair price" (the price published by the U.S. Secretary of Health and Human Services), "price applicability period" (a timeframe specified in federal code), and "referenced drug" (a drug subject to a maximum fair price). The legislation prohibits any person or entity in Arizona from purchasing or seeking reimbursement for a referenced drug at a price higher than its maximum fair price, excluding pharmacy dispensing fees. Violations of these pricing restrictions are considered unlawful practices under consumer protection laws, giving the state Attorney General the authority to investigate and take enforcement action. Additionally, the bill allows individuals who are harmed by such pricing violations to pursue private legal action for consumer fraud. This approach aims to protect consumers from excessive prescription drug pricing by aligning state regulations with federal pricing guidelines.

Health and Social Services

https://apps.azleg.gov/BillStatus/BillOverview/82808